Gilder Gagnon Howe & CO LLC Amicus Therapeutics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $20.1 Million - $24.7 Million	-2,305,432 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $438,665 - $1.14 Million	47,681 Added 2.11%	2,305,432 $22.8 Million
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $2.33 Million - $4.31 Million	173,009 Added 8.3%	2,257,751 $52.1 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $538,402 - $663,709	-41,769 Reduced 1.96%	2,084,742 $29.4 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $18.8 Million - $33.4 Million	2,126,511 New	2,126,511 $32.1 Million
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $120,300 - $198,750	-15,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $164,400 - $216,000	15,000 New	15,000 $187,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.